LUMO
Price:
$4.34
Market Cap:
$37.54M
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
Industry
Biotechnology
IPO Date
2011-11-11
Stock Exchange
NASDAQ
Ticker
LUMO
According to Lumos Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 24.19M. This represents a change of 217.29% compared to the average of 7.62M of the last 4 quarters.
The mean historical Enterprise Value of Lumos Pharma, Inc. over the last ten years is 203.79M. The current 24.19M Enterprise Value has changed 1.09% with respect to the historical average. Over the past ten years (40 quarters), LUMO's Enterprise Value was at its highest in in the March 2015 quarter at 1.34B. The Enterprise Value was at its lowest in in the March 2020 quarter at -66115057.00.
Average
203.79M
Median
50.10M
Minimum
-64103342.56
Maximum
917.05M
Discovering the peaks and valleys of Lumos Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.82%
Maximum Annual Enterprise Value = 917.05M
Minimum Annual Increase = -167.28%
Minimum Annual Enterprise Value = -64103342.56
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | -8591407.10 | -66.37% |
| 2022 | -25544509.80 | -30.00% |
| 2021 | -36493804.12 | -125.40% |
| 2020 | 143.68M | 2.82% |
| 2019 | 4.93M | -107.69% |
| 2018 | -64103342.56 | -167.28% |
| 2017 | 95.28M | -42.84% |
| 2016 | 166.70M | -80.27% |
| 2015 | 845.01M | -7.86% |
| 2014 | 917.05M | 82.66% |
The current Enterprise Value of Lumos Pharma, Inc. (LUMO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-23543240.34
5-year avg
15.60M
10-year avg
203.79M
Lumos Pharma, Inc.’s Enterprise Value is greater than Satsuma Pharmaceuticals, Inc. (20.18M), less than Eyenovia, Inc. (38.86M), less than Pluristem Therapeutics Inc. (43.29M), greater than Cerecor Inc. (-3660587.00), greater than LianBio (-40025352.00), greater than Magenta Therapeutics, Inc. (-12257976.00), less than Grace Therapeutics, Inc. (29.31M), less than Lunai Bioworks Inc. (35.00M), less than Oruka Therapeutics, Inc. (1.06B), less than Opus Genetics, Inc. (118.89M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 20.18M | $36.47M | |
| 38.86M | $38.59M | |
| 43.29M | $40.85M | |
| -3660587.00 | $38.63M | |
| -40025352.00 | $11.68M | |
| -12257976.00 | $42.44M | |
| 29.31M | $46.17M | |
| 35.00M | $32.92M | |
| 1.06B | $1.15B | |
| 118.89M | $151.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lumos Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lumos Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lumos Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lumos Pharma, Inc. (LUMO)?
What is the 3-year average Enterprise Value for Lumos Pharma, Inc. (LUMO)?
What is the 5-year average Enterprise Value for Lumos Pharma, Inc. (LUMO)?
How does the current Enterprise Value for Lumos Pharma, Inc. (LUMO) compare to its historical average?